REFERENCES

1.. Bayliss WM, Starling EH: The mechanism of pancreatic secretion. J Physiol  1902; 28:325-353.

2.. Medvei VC: A History of Endocrinology.  Hingham, MA, MTP Press, 1982.

3..  Clinical Society of London: Report on myxoedema. Boston, 1888, Francis A. Countway Library of Medicine.

4.. Ord WM: On myxoedema, a term proposed to be applied to an essential condition in the “cretinoid” affection occasionally observed in middle-aged women. Medico-chirurgical Trans  1978; 61:57-78.

5.. Murray G: Note on the treatment of myxoedema by hypodermic injections of an extract of the thyroid gland of a sheep. Br Med J  1891; 2:796-797.

6.. Bliss M: The Discovery of Insulin.  Chicago, The University of Chicago Press, 1982.

7.. Von Mering J, Minkowski O: Diabetes mellitis nach pankreas extirpation. Arch Exp Path Pharmakol  1890; 26:371-387.

8.. Collip JB: The original method as used for the isolation of insulin in semi pure form for the treatment of the first clinical cases. J Biol Chem  1923; 55:50-51.

9.. Collip JB: The extraction of a parathyroid hormone that will prevent or control parathyroid tetany and which regulates the level of blood calcium. J Biol Chem  1925; 63:395-438.

10.. Sutherland EW, Oye I, Butcher RW: The action of epinephrine and the role of the adenyl cyclase system in hormone action. Recent Prog Horm Res  1965; 21:623-646.

11.. Tata JR, Widnell CC: Ribonucleic acid synthesis during the early action of thyroid hormone. Biochem J  1966; 98:604-620.

12.. Berson SA, Yalow RS: Radioimmunoassays of peptide hormones in plasma. N Engl J Med  1967; 277:640-647.

13.. Means JH: Historical background of the use of radioactive iodine in medicine. N Engl J Med  1955; 252:936-940.

14.. Astwood EB: Treatment of hyperthyroidism with thiourea. J Am Med Assoc  1943; 122:78-81.

15.. Thorner MO, McNeilly AS, Hagan C, et al: Long-term treatment of galactorrhoea and hypogonadism with bromocriptine. Br Med J  1974; 2:419-422.

16..  Loubatieres A: These Doctorat No. 86. Sci naturelles. Montpellier, France, 1946, Montpellier.

17.. Pincus G: Control of conception by hormonal steroids. Science  1966; 153:493-500.

18.. Lamberts SW, Uitterlinden P, Verschoor L, et al: Long-term treatment of acromegaly with the somatostatin analogue SMS 201-995. N Engl J Med  1985; 313:1576-1580.

19.. Itakura K, Hirose T, Crea R, et al: Expression in Escherichia coli of a chemically synthesized gene for the hormone somatostatin. Science  1977; 198:1056-1063.

20.. Seeburg PH, Shine J, Martial JA, et al: Nucleotide sequence and amplification in bacteria of structural gene for rat growth hormone. Nature  1977; 270:486-494.

21.. Ullrich A, Shine J, Chirgwin J, et al: Rat insulin genes: Construction of plasmids containing the coding sequences. Science  1977; 196:1313-1319.

22.. Fiddes JC, Goodman HM: Isolation, cloning and sequence analysis of the cDNA for the alpha-subunit of human chorionic gonadotropin. Nature  1979; 281:351-356.

23.. Minokoshi Y, Kahn CR, Kahn BB: Tissue-specific ablation of the GLUT4 glucose transporter or the insulin receptor challenges assumptions about insulin action and glucose homeostasis. J Biol Chem  2003; 278:33609-33612.

24.. Brennan MD, Miner KM, Rizza RA: The Mayo Clinic. J Clin Endocrinol Metab  1988; 83:3427-3434.

25.. Biller BMK, Swearingen B, Zervas NT, et al: A decade of the Massachusetts General Hospital neuroendocrine clinical center. J Clin Endocrinol Metab  1997; 82:1668-1674.

26.. List JF, Habener JF: Defective melanocortin 4 receptors in hyperphagia and morbid obesity. N Engl J Med  2003; 348:1160-1163.